Open Access
Open access
volume 42 issue 38 pages 2783-2800

Going circular: history, present, and future of circRNAs in cancer

Publication typeJournal Article
Publication date2023-08-16
scimago Q1
wos Q1
SJR2.489
CiteScore15.4
Impact factor7.3
ISSN09509232, 14765594
Cancer Research
Molecular Biology
Genetics
Abstract

To date, thousands of highly abundant and conserved single-stranded RNA molecules shaped into ring structures (circRNAs) have been identified. CircRNAs are multifunctional molecules that have been shown to regulate gene expression transcriptionally and post-transcriptionally and exhibit distinct tissue- and development-specific expression patterns associated with a variety of normal and disease conditions, including cancer pathogenesis. Over the past years, due to their intrinsic stability and resistance to ribonucleases, particular attention has been drawn to their use as reliable diagnostic and prognostic biomarkers in cancer diagnosis, treatment, and prevention. However, there are some critical caveats to their utility in the clinic. Their circular shape limits their annotation and a complete functional elucidation is lacking. This makes their detection and biomedical application still challenging. Herein, we review the current knowledge of circRNA biogenesis and function, and of their involvement in tumorigenesis and potential utility in cancer-targeted therapy.

Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
8
9
International Journal of Molecular Sciences
9 publications, 5.2%
Non-coding RNA Research
4 publications, 2.31%
Pathology Research and Practice
4 publications, 2.31%
Frontiers in Oncology
4 publications, 2.31%
Molecular Cancer
4 publications, 2.31%
Cell Death and Disease
4 publications, 2.31%
Discover Oncology
4 publications, 2.31%
Scientific Reports
3 publications, 1.73%
Cells
3 publications, 1.73%
International Journal of Biological Macromolecules
3 publications, 1.73%
Frontiers in Immunology
3 publications, 1.73%
Cancer Cell International
3 publications, 1.73%
Non-coding RNA
2 publications, 1.16%
Medical Oncology
2 publications, 1.16%
Frontiers in Genetics
2 publications, 1.16%
Critical Reviews in Oncology/Hematology
2 publications, 1.16%
BMC Genomics
2 publications, 1.16%
Oncogene
2 publications, 1.16%
Cancer Drug Resistance
2 publications, 1.16%
Cell Death Discovery
2 publications, 1.16%
Clinica Chimica Acta
2 publications, 1.16%
Gene
2 publications, 1.16%
Life Sciences
2 publications, 1.16%
Biochemical Pharmacology
2 publications, 1.16%
Biomedicine and Pharmacotherapy
2 publications, 1.16%
Cellular and Molecular Biology Letters
2 publications, 1.16%
Naunyn-Schmiedeberg's Archives of Pharmacology
2 publications, 1.16%
Advances in Experimental Medicine and Biology
2 publications, 1.16%
Redox Biology
1 publication, 0.58%
1
2
3
4
5
6
7
8
9

Publishers

10
20
30
40
50
60
Springer Nature
56 publications, 32.37%
Elsevier
41 publications, 23.7%
MDPI
22 publications, 12.72%
Frontiers Media S.A.
16 publications, 9.25%
Wiley
13 publications, 7.51%
Spandidos Publications
4 publications, 2.31%
Taylor & Francis
4 publications, 2.31%
Bentham Science Publishers Ltd.
2 publications, 1.16%
OAE Publishing Inc.
2 publications, 1.16%
American Chemical Society (ACS)
2 publications, 1.16%
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.16%
BMJ
1 publication, 0.58%
Oxford University Press
1 publication, 0.58%
Moffitt Cancer Center
1 publication, 0.58%
Cold Spring Harbor Laboratory
1 publication, 0.58%
Pleiades Publishing
1 publication, 0.58%
SAGE
1 publication, 0.58%
Portland Press
1 publication, 0.58%
Apex Publishing
1 publication, 0.58%
10
20
30
40
50
60
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
174
Share
Cite this
GOST |
Cite this
GOST Copy
Pisignano G. et al. Going circular: history, present, and future of circRNAs in cancer // Oncogene. 2023. Vol. 42. No. 38. pp. 2783-2800.
GOST all authors (up to 50) Copy
Pisignano G., Michael D. C., Visal T. H., Pirlog R., LADOMERY M. R., Calin G. A. Going circular: history, present, and future of circRNAs in cancer // Oncogene. 2023. Vol. 42. No. 38. pp. 2783-2800.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41388-023-02780-w
UR - https://doi.org/10.1038/s41388-023-02780-w
TI - Going circular: history, present, and future of circRNAs in cancer
T2 - Oncogene
AU - Pisignano, Giuseppina
AU - Michael, David C.
AU - Visal, Tanvi H
AU - Pirlog, Radu
AU - LADOMERY, MICHAEL R.
AU - Calin, George A.
PY - 2023
DA - 2023/08/16
PB - Springer Nature
SP - 2783-2800
IS - 38
VL - 42
PMID - 37587333
SN - 0950-9232
SN - 1476-5594
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Pisignano,
author = {Giuseppina Pisignano and David C. Michael and Tanvi H Visal and Radu Pirlog and MICHAEL R. LADOMERY and George A. Calin},
title = {Going circular: history, present, and future of circRNAs in cancer},
journal = {Oncogene},
year = {2023},
volume = {42},
publisher = {Springer Nature},
month = {aug},
url = {https://doi.org/10.1038/s41388-023-02780-w},
number = {38},
pages = {2783--2800},
doi = {10.1038/s41388-023-02780-w}
}
MLA
Cite this
MLA Copy
Pisignano, Giuseppina, et al. “Going circular: history, present, and future of circRNAs in cancer.” Oncogene, vol. 42, no. 38, Aug. 2023, pp. 2783-2800. https://doi.org/10.1038/s41388-023-02780-w.
Profiles